SLAMF1 antibody
Quick Overview for SLAMF1 antibody (ABIN951192)
Target
See all SLAMF1 AntibodiesReactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Specificity
- This Monoclonal SLAM.4 antibody recognizes CD150, a cell surface molecule expressed on lymphocytes and involved in their activation.
-
Cross-Reactivity (Details)
- Species reactivity (tested):Human.
-
Purification
- Protein A-affinity chromatography
-
Immunogen
- Human CD150-transfected 300.19 cells
-
Isotype
- IgG1
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Concentration
- 1.0 mg/mL (> 95% pure by SDS-PAGE)
-
Buffer
- Azide free phosphate buffered saline (PBS), pH ~7.4, 0.2 μm filter sterilized
-
Preservative
- Azide free
-
Handling Advice
- Avoid repeated freezing and thawing.
-
Storage
- 4 °C/-20 °C
-
Storage Comment
- Store the antibody at 2 - 8 °C up to one month or (in aliquots) at -20 °C for longer.
-
-
- SLAMF1 (Signaling Lymphocytic Activation Molecule Family Member 1 (SLAMF1))
-
Alternative Name
- CD150 / SLAMF1
-
Background
- CD150, also known as SLAM (signaling lymphocyte activation molecule) is a 70-95 kDa single chain transmembrane phosphoglycoprotein of the CD2 family. Its extracellular part contains eight potential N-glycosylation sites, and the intracellular tail contains three unique tyrosine-based motifs. These binding sites can be recognized by SH2-binding phosphatases and the adaptor proteins, such as SAP/SH2D1A or EAT-2. The SLAM family receptors are involved in leucocyte activation and contribute to the effective germinal center formation, generation of high-affinity antibody-secreting plasma cells, and memory T and B cells, thereby facilitating long-term immune response. CD150 expression is upregulated after cell activation.Synonyms: CDw150, Ipo-3, Signaling lymphocytic activation molecule, Slam
-
Gene ID
- 6504
-
NCBI Accession
- NP_003028
-
UniProt
- Q13291
Target
-